Single EU patent court delayed ‘until 2016 or beyond’ as jurisdiction amended
This article was originally published in Scrip
The European Commission is planning to update the legislation on court jurisdiction and the recognition of judgments in order to allow the future Unified Patent Court to enter into force as soon as possible. But the upshot of this enabling measure is that the Court is unlikely to be operational until 2016 or beyond, as the national and internecine politics play out.
You may also be interested in...
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.
Recommending new medicines for approval and allowing sponsors of others extra time to answer outstanding questions are among the many tasks on the agenda of the March meeting of European Medicines Agency's key scientific committee, the CHMP. The meeting has been taking place, remotely, this week.
AMD patients in the UK can legitimately be given compounded bevacizumab (Roche’s Avastin) after the appeals court said NHS trusts could offer a drug off-label for economic reasons where there were no safety or efficacy concerns.